Mississippi's Point out Board of Clinical Licensure now prohibits prescribing, dispensing, or administrating compounded semaglutide for weight-loss, citing basic safety problems, but laws fluctuate from point out to condition. Customers can consult with the FDA's BeSafeRx marketing campaign